CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
Argus Research Sticks to Its Buy Rating for CVS Health (CVS)
In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The ...
Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?
Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...
CVS Health price target raised to $77 from $68 at Argus
Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...
Good e-Reader19h
The Braille Institute Launches New Font for e-readers
The Braille Institute has just launched their Atkinson Hyperlegible Next, now with enhanced characters, upgraded with seven ...